Clinical Trial Update: A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men [Phase 1]

View source ↗

Summary

Phase 1 study assessing how severe hepatic impairment affects the metabolism, safety, and tolerability of a single oral dose of enzalutamide in men; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Severe Hepatic Impairment, Normal Hepatic Function | Phase 1 | Status: COMPLETED